combination chemotherapy

Conservative Chemotherapy in Gestational Trophoblastic Disease: Experience With Etoposide, Methotrexate, and Dactinomycin Chemotherapy
Seung Won Byun, Tae Chul Park, Seog Nyeon Bae

International Journal of Gynecologic Cancer May 2016, 26 (4) 790-795; DOI: 10.1097/IGC.0000000000000671
The Significance of Combination Chemotherapy in Epithelial Ovarian Cancer
Janice S. Kwon, Colleen McGahan, Ulrike Dehaeck, Jennifer Santos, Kenneth Swenerton, Mark S. Carey

International Journal of Gynecologic Cancer Feb 2014, 24 (2) 226-232; DOI: 10.1097/IGC.0000000000000055
The Impact of Geographic Variations in Treatment on Outcomes in Ovarian Cancer
Ulrike Dehaeck, Colleen E. McGahan, Jennifer L. Santos, Mark S. Carey, Kenneth D. Swenerton, Janice S. Kwon

International Journal of Gynecologic Cancer Feb 2013, 23 (2) 282-287; DOI: 10.1097/IGC.0b013e31827b87b1
Recurrent small cell carcinoma of the ovary treated with docetaxel: a case report
S. Niimi, T. Kiyokawa, S. Takakura, K. Ochiai, T. Tanaka

International Journal of Gynecologic Cancer Sep 2006, 16 (5) 1944-1946; DOI: 10.1136/ijgc-00009577-200609000-00035
Primary peritoneal carcinoma: experience with cytoreductive surgery and combination chemotherapy
J. H. Nam, Y. M. Kim, M. H. Jung, K. R. Kim, H. J. Yoo, D. Y. Kim, J. H. Kim, Y. T. Kim, J. E. Mok

International Journal of Gynecologic Cancer Jan 2006, 16 (1) 23-28; DOI: 10.1136/ijgc-00009577-200601000-00004
Treatment of recurrent disease: randomized trials of monotherapy versus combination chemotherapy
A. GONZÁLEZ-MARTÍN

International Journal of Gynecologic Cancer Nov 2005, 15 (Suppl 3) 241-246; DOI: 10.1136/ijgc-00009577-200511001-00010
Undifferentiated endometrial carcinoma of the uterus: marked effect of chemotherapy with tetrahydropyranyl-adriamycin, paclitaxel, and carboplatin
M. Hayashi, Y. Ueda, T. Takimoto, T. Ohkura

International Journal of Gynecologic Cancer Feb 2004, 14 (2) 388-394; DOI: 10.1136/ijgc-00009577-200403000-00032
Is combination chemotherapy superior to single-agent chemotherapy in second-line treatment?
A. González-Martín

International Journal of Gynecologic Cancer Oct 2003, 13 (Suppl 2) 185-191; DOI: 10.1136/ijgc-00009577-200311001-00010
Mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) chemotherapy for gynecological sarcomas
M. L. Pearl, M. Inagami, D. L. Mccauley, F. A. Valea, E. Chalas, M. Fischer

International Journal of Gynecologic Cancer Oct 2002, 12 (6) 745-748; DOI: 10.1136/ijgc-00009577-200211000-00010
Gemcitabine in the treatment of ovarian cancer
S. W. Hansen

International Journal of Gynecologic Cancer Jul 2001, 11 (Suppl 1) 39-41; DOI: 10.1136/ijgc-00009577-200107001-00009

Log in using your username and password

Main menu

Log in using your username and password

You are here

combination chemotherapy